February 1, 2024
Penta – Child Health Research announces new partnership with IAVI and Achilles Vaccines
Partnership will advance monoclonal antibody development.
Penta – Child Health Research announced today a new partnership with IAVI and Achilles Vaccines focused on the development of innovative monoclonal antibodies for pediatric HIV infections, for both preventive and therapeutic use. The partnership’s goal is to develop affordable, accessible new tools to address existing unmet needs for pediatric HIV. The partnership will additionally advance work targeting emerging infections and neglected diseases affecting children.
Read Penta’s press release for more information.